Funded Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-02	Rachel Altshuler, Ph.D.
Grace, Peter M	University Of Tx Md Anderson Can Ctr United States	PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain	5R01CA227064-06	Catherine Schweppe, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	High-resolution mutational landscape of the primed colon in early onset colorectal cancer	3U54CA274374-02S1	Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	High-resolution mutational landscape of the primed colon in early onset colorectal cancer	3U54CA274374-02S1	Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	High-resolution mutational landscape of the primed colon in early onset colorectal cancer	3U54CA274374-02S1	Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	High-resolution mutational landscape of the primed colon in early onset colorectal cancer	3U54CA274374-02S1	Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-02	Matthew Young, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-02	Matthew Young, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-02	Matthew Young, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-02	Matthew Young, Ph.D.